Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-147826
Filing Date
2024-05-28
Accepted
2024-05-28 12:04:28
Documents
8
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 6-K d839421d6k.htm 6-K 11544
2 EX-99.1 d839421dex991.htm EX-99.1 22496
3 EX-99.2 d839421dex992.htm EX-99.2 21131
4 EX-99.3 d839421dex993.htm EX-99.3 39849
5 EX-99.4 d839421dex994.htm EX-99.4 18868
6 EX-99.5 d839421dex995.htm EX-99.5 26464
7 GRAPHIC g839421g0527225640753.jpg GRAPHIC 2601
8 GRAPHIC g839421g06x08.gif GRAPHIC 1049
  Complete submission text file 0001193125-24-147826.txt   146800
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 24988577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)